English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Epigenetic dosage identifies two major and functionally distinct β cell subtypes

MPS-Authors

Dror,  Erez
Department of Epigenetics, Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

Wegert,  Vanessa
Department of Epigenetics, Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

Panzeri,  Ilaria
Department of Epigenetics, Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

Heyne,  Steffen
Department of Epigenetics, Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

Höffler,  Kira Daniela
Department of Epigenetics, Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

Kreiner,  Victor
Department of Epigenetics, Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

Ching,  Reagan
Department of Epigenetics, Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

Lu,  Tess Tsai-Hsiu
Department of Epigenetics, Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

Lempradl,  Adelheid
Department of Epigenetics, Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

/persons/resource/persons198873

Pospisilik,  John Andrew
Department of Epigenetics, Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)

10.1016_j.cmet.2023.03.008.pdf
(Publisher version), 5MB

Supplementary Material (public)
There is no public supplementary material available
Citation

Dror, E., Fagnocchi, L., Wegert, V., Apostle, S., Grimaldi, B., Gruber, T., et al. (2023). Epigenetic dosage identifies two major and functionally distinct β cell subtypes. Cell Metabolism, 35, 821-836. doi:10.1016/j.cmet.2023.03.008.


Cite as: https://hdl.handle.net/21.11116/0000-000D-1026-6
Abstract
The mechanisms that specify and stabilize cell subtypes remain poorly understood. Here, we identify two major subtypes of pancreatic β cells based on histone mark heterogeneity (βHI and βLO). βHI cells exhibit ∼4-fold higher levels of H3K27me3, distinct chromatin organization and compaction, and a specific transcriptional pattern. βHI and βLO cells also differ in size, morphology, cytosolic and nuclear ultrastructure, epigenomes, cell surface marker expression, and function, and can be FACS separated into CD24+ and CD24- fractions. Functionally, βHI cells have increased mitochondrial mass, activity, and insulin secretion in vivo and ex vivo. Partial loss of function indicates that H3K27me3 dosage regulates βHILO ratio in vivo, suggesting that control of β cell subtype identity and ratio is at least partially uncoupled. Both subtypes are conserved in humans, with βHI cells enriched in humans with type 2 diabetes. Thus, epigenetic dosage is a novel regulator of cell subtype specification and identifies two functionally distinct β cell subtypes.